N. B. Epshtein

N. B. Epshtein

Auto-generated profile, based on publicly available information

N. B. Epshtein

National Research Nuclear University MEPhI

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2015 in Annals of the Russian academy of medical sciences
Verified
Journal Article
Open access
OVO.P. Vlasova
O.P. Vlasova
Konstantin Eduardovich GermanKonstantin Eduardovich German
Konstantin Eduardovich German
VKV.V. Krylov
V.V. Krylov
VPV.M. Petriev
V.M. Petriev
NEN.B. Epshtein
N.B. Epshtein
About 10.7% cases of prostate cancer were registered in Russia in 2011 (40,000 patients). More than half of cancer cases were revealed in advanced (III-IV) stages when metastases inevitably developed quickly. Clinical problem of early diagnostics and treatment of metastatic prostate cancer is still not solved. Anatomical imaging techniques have low sensitivity and specificity for the detection of this disease. Metabolic visualization methods which use prostate specific antigen (PSA) as a marker are also ineffective. This article describes prostate-specific membrane antigens (PSMA) that are proposed as a marker for diagnostics and therapy of prostate cancer. The most promising PSMA-based radiopharmaceutical agent for diagnostics has been developed and clinically tested in the European countries. These pharmaceuticals are based on small peptide molecules modified with urea, and have the highest affinity to PSMA. Favorable phannacokinetics, rapid accumulation in the tumor and rapid excretion from the body are beneficial features of these pharmaceuticals.

1 July 2017 in Journal of Analytical Chemistry
Verified
Journal Article
Closed access
PDF file
PPP.A. Poluboyarinov*
P.A. Poluboyarinov*
PLP. P. Leshchenko
P. P. Leshchenko
IMI. Ya. Moiseeva
I. Ya. Moiseeva
SKS. G. Kolesnikova
S. G. Kolesnikova
NEN. B. Epshtein
N. B. Epshtein
Products of reaction between the organoselenium xenobiotic, diacetophenonyl selenide (1,5-diphenyl-3-selenapenta-1,5-dione), and reduced glutathione at different molar ratios and pH values were studied by HPLC and TLC. Reaction intermediates, S-(acetophenylselenyl)glutathione and glutathione selenodisulfide, and reaction products, acetophenone and hydroselenide anion, were detected. The reaction scheme proposed earlier was confirmed.

1 January 2025 in Voprosy praktičeskoj pediatrii
Verified
Journal Article
Closed access
VYV.G. Yankova
V.G. Yankova
OGOleg Gobyzov
Oleg Gobyzov
MRMikhail Ryabov
Mikhail Ryabov
VGVictoria Grigorieva
Victoria Grigorieva
IUI.L. Udyanskaya
I.L. Udyanskaya
SGS.V. Gribanova
S.V. Gribanova
The effectiveness of delivery of pharmaceutical sprays containing the same active substance in the same concentration to the focal point of inflammation in the treatment of throat diseases depends on the quality of spraying of the drug. Objective. Comparative analysis of the spray parameters of 8 benzidamine drugs produced in the form of a metered-dose spray to select a drug with optimal spray quality characteristics. Materials and methods. The study included 8 drugs in the form of metered-dose sprays for topical use containing benzydamine and approved for use in children aged 3 years and older: Tantum® Verde (marketing certificate holder Angelini Pharma SpA, Italy), Oralsept® (marketing certificate holder Gedeon Richter Plc., Hungary), Lorangin® (marketing certificate holder Penta Group Research and Production Association LLC, Russia), VERTUM-LOR (VERTEX JSC, Russia), Faringosprey (marketing certificate holder Sun Pharmaceutical Industries Ltd., India), FARINORM® Benzydamine (marketing certificate holder YuzhPharm LLC, Russia), INLARTEX (marketing certificate holder Tula Pharmaceutical Factory LLC, Russia), Anestojet (marketing certificate holder IRIS LLC, Russia). For all samples, the dose mass reproducibility (DMR), spray width and pattern, spray dynamic characteristics, and brightness profile were studied. Results. The AMD test showed that the mean dose masses differ insignificantly, and reproducibility is characterized by a relative error of only 1–2% for all drugs, indicating good dosing stability. The test for spray pattern and distribution, conducted on a simulation model based on the area of a single spray deposition, showed that the widest and most uniform spray, which promotes the most complete deposition of the drugs in the oral cavity, is achieved with Tantum® Verde and Oralsept®. A comparative analysis of the sprays by dynamic characteristics confirmed the conclusion of the previous test that these drugs have the most favorable spray mechanism for delivering the drug to the site of inflammation and correspond to classic sprays. Conclusion. The improved dynamic performance of the drug's spray mechanism facilitates more effective drug delivery to the site of action – the site of inflammation. Tantum® Verde and Oralsept® sprays exhibit the most favorable dynamic performance. Their performance is virtually identical across all tests. Key words: benzydamine, dose mass reproducibility, cone angle, cone shape, acute respiratory infections, metered-dose spray

30 August 2024 in "Medical & Pharmaceutical Journal "Pulse"
Verified
Journal Article
Closed access
MEMolokhova E.I.
Molokhova E.I.
GRGoldyrev R.V.
Goldyrev R.V.
KNKovyazina N.A.
Kovyazina N.A.
ENEpshtein N.B.
Epshtein N.B.
Aim. Comparative evaluation of the shells of solid capsules made of gelatin and hypromelose of hygroscopicity and disintegration indicators. Materials and Methods. Solid gelatin and hypromellose capsules produced by Capsugel (Belgium), as well as pharmaceutical compositions with bifidobacterium lyophilisate were used as objects of research. Hygroscopicity was determined according to FEES methods. Hygroscopicity is determined by the weight method according to the GF RF XV according to the OFS.1.1.0042 "Determination of hygroscopicity". The water-absorbing properties of capsule shells were evaluated by the rate of moisture gain of empty and filled solid capsules. Tests on the disintegration index were conducted according to the GF of the Russian Federation XV, OFS.1.4.2.0013 "Disintegration of solid dosage forms", OFS.1.7.1.0003.15 "Bifido-containing probiotics". Results. Comprehensive pharmaceutical-technological studies of empty hard capsules and model samples with encapsulated composition with bifidobacterium lyophilisate in hard capsules produced by Capsugel® (Belgium) were carried out. As a result of comparative analysis of characteristics of empty hard capsules Coni-Snap and Vcaps Plus, it was revealed that Vcaps Plus capsules have faster disintegration, higher rate of moisture gain, low hygroscopicity of the capsulated composition with preservation of the shape and structure of the capsule shell. Conclusion. Comparative studies of the water-absorption properties of gelatin and hypromellose capsules have shown the rationality of using hypromellose capsules for encapsulating hygroscopic AFS, in particular lyophilizates.

22 January 2024 in Drug development & registration
Verified
Journal Article
Open access
PDF file
SGS. V. Gribanova
S. V. Gribanova
IUI. L. Udyanskaya
I. L. Udyanskaya
VYV. G. Yankova
V. G. Yankova
TSTatiana Slonskaya
Tatiana Slonskaya
NEN. B. Epshtein
N. B. Epshtein
VKV. N. Kuzina
V. N. Kuzina
Introduction. In modern medicine, the requirements for the quality of used materials are getting stricter. There is serious concern about bacterial and fungal contamination related to the use of silicone polymeric products, especially those that are in direct contact with human tissues and body fluids. In this regard, the issue of impregnating silicone medical products with various biologically active substances (BAS), particularly with antimicrobial properties, appears relevant.Aim. The research studies the relevance of adding BAS into silicone medical devices to improve their quality and prevent negative consequences of their use. The authors of the article aimed at proving prolonged release of the chosen BAS from silicone products during their contact with skin and the bacteriostatic effect emerging as a result of the BAS release. That required verifying the existence of BAS in the washouts from silicone disks, which, in turn, proves the fact that BAS initially distributed evenly in the volume of a silicone disk are capable of diffusing to the surface and then releasing from it under mechanical action, as well as when treating it with alcohol or alcohol-containing solutions.Materials and methods. Symdiol and bisabolol were selected as the BAS for this study due to their proved antibacterial, anti-inflammatory and moisturizing properties. Bisabolol and symdiol were used in the form of Dragosantol 100 and SymDiol 68T preparations correspondingly. Silicone disks (SDs), impregnated with BAS (0,2 % of the volume) were used as a simulation model of silicone liners. The BAS release from silicone liner models was assessed using highly sensitive chromatographic methods of thin-layer and gas-liquid chromatography.Results and discussion. The method of impregnating SDs with BAS was worked out, the optimal concentration of these substances to add them into the silicone base was selected. The release of the impregnated additives, as well as prolonged stable releasing effect, were confirmed. The data obtained during the experiment allows saying with confidence that the impregnated preparation (symdiol and bisabolol) releases from a SD even upon short and low-intensity mechanical contact with skin, which produces stable bacteriostatic effect on a wide range of microorganisms. The process of BAS release from SDs is also facilitated when treating the product periodically with alcohol-containing solutions, which is necessary according to the operating rules. The obtained results of the chromatographic research quite correlate with the data of the previous microbiological experiments regarding the studied topic. Release of the studied BAS from polymer products during their contact with the skin within the period of not less than 3 months justifies feasibility of adding these BAS into the silicone base.Conclusions. The study confirmed the release of biologically active substances from silicone medical products. Adding BAS into silicone liners undoubtedly improves the quality of these medical products, which can be applied in prosthetics and orthoses.

30 January 2014 in Journal of Analytical Chemistry
Verified
Journal Article
Closed access
PDF file
GKG. M. Khomushku
G. M. Khomushku
YBYu. S. Brezhneva
Yu. S. Brezhneva
VPV. S. Puchnin
V. S. Puchnin
SMS. M. Moiseeva
S. M. Moiseeva
NEN. B. Epshtein
N. B. Epshtein
Optimal conditions are found for the simultaneous determination of tranexamic acid, ampasse, and ethylmethylhydroxypyridine succinate by reversed-phase HPLC. As is shown, under these conditions the reversed-phase mechanism of retention prevails and the analytes occur mainly in a specific ionic state with an optimal retention time. The possibility of using chromatography columns from various manufacturers is estimated. The method was used to analyze title materials and impurities in drug formulations.